As employers across the country weigh the cost of covering GLP-1 medications for obesity, Bank of America is taking a different approach: keep providing access, work to bring costs down and view obesity treatment as an investment in employees. The Obesity Action Coalition (OAC) applauds that approach. Bank of America CEO Brian Moynihan recently told
Read Article